IRIS
PELAIA, GIROLAMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.895
AS - Asia 3.270
EU - Europa 1.467
SA - Sud America 1.058
AF - Africa 60
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 7
Totale 9.765
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.726
SG - Singapore 1.480
BR - Brasile 833
CN - Cina 708
IT - Italia 707
VN - Vietnam 466
IN - India 337
DE - Germania 184
GB - Regno Unito 155
SE - Svezia 143
CA - Canada 117
AR - Argentina 100
HK - Hong Kong 74
FI - Finlandia 69
EC - Ecuador 43
ID - Indonesia 41
BD - Bangladesh 37
MX - Messico 32
NL - Olanda 28
RU - Federazione Russa 25
ES - Italia 23
PY - Paraguay 21
FR - Francia 20
PL - Polonia 20
UA - Ucraina 20
IQ - Iraq 19
TR - Turchia 18
ZA - Sudafrica 18
CL - Cile 16
JP - Giappone 16
CZ - Repubblica Ceca 13
PE - Perù 13
VE - Venezuela 13
PK - Pakistan 12
CO - Colombia 11
EG - Egitto 11
MA - Marocco 11
DO - Repubblica Dominicana 9
IE - Irlanda 9
UZ - Uzbekistan 8
AT - Austria 7
LT - Lituania 7
RO - Romania 7
UY - Uruguay 7
AU - Australia 6
IL - Israele 6
KE - Kenya 6
EU - Europa 5
IR - Iran 5
SA - Arabia Saudita 5
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
DK - Danimarca 4
DZ - Algeria 4
JO - Giordania 4
KZ - Kazakistan 4
LB - Libano 4
MY - Malesia 4
TT - Trinidad e Tobago 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CH - Svizzera 3
HR - Croazia 3
PT - Portogallo 3
TN - Tunisia 3
BG - Bulgaria 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CR - Costa Rica 2
EE - Estonia 2
GR - Grecia 2
HN - Honduras 2
HU - Ungheria 2
KG - Kirghizistan 2
KR - Corea 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
GY - Guiana 1
LV - Lettonia 1
ML - Mali 1
MR - Mauritania 1
NC - Nuova Caledonia 1
NE - Niger 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SC - Seychelles 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
Totale 9.765
Salva come PNG Salva come JPEG
Città #
Chandler 574
Singapore 480
Dallas 363
Santa Clara 303
Bengaluru 288
Hefei 288
Milan 245
Lawrence 227
Princeton 227
Ho Chi Minh City 186
Ashburn 170
Wilmington 144
Munich 117
Chicago 114
London 114
Hanoi 93
Ottawa 91
Beijing 86
São Paulo 77
Hong Kong 72
Des Moines 71
Catanzaro 67
Turku 51
Boardman 47
Los Angeles 30
Shanghai 30
Naples 29
New York 25
Rio de Janeiro 25
Da Nang 24
Rome 24
San Francisco 22
Quito 20
Warsaw 20
Atlanta 19
Guangzhou 19
Redwood City 19
Brooklyn 18
Norwalk 18
The Dalles 18
Haiphong 17
Palermo 17
Seattle 17
Biên Hòa 16
Buenos Aires 16
Hanover 16
San Nicola Manfredi 16
Boston 15
Helsinki 15
Redmond 15
Troina 15
Belo Horizonte 14
Mexico City 13
Olomouc 13
Thái Bình 13
Columbus 12
Curitiba 12
Florence 12
Guayaquil 12
Phoenix 12
Tokyo 12
Ankara 11
Hải Dương 11
Lima 11
Salvador 11
Ninh Bình 10
Baghdad 9
Campinas 9
Council Bluffs 9
Dhaka 9
Pune 9
Shenzhen 9
Asunción 8
Brasília 8
Dublin 8
Johannesburg 8
Osasco 8
Tashkent 8
Toronto 8
Amsterdam 7
Augusta 7
Bauru 7
Cape Town 7
Falls Church 7
Goiânia 7
Guarulhos 7
Mendoza 7
Porto Alegre 7
Rogliano 7
Stockholm 7
Wuhan 7
Assago 6
Bologna 6
Bắc Giang 6
Cairo 6
Caxias do Sul 6
Ferrara 6
Florianópolis 6
Londrina 6
Mountain View 6
Totale 5.457
Salva come PNG Salva come JPEG
Nome #
Ascaris lumbricoides-induced suppression of total and specific IgE responses in atopic subjects is interleukin 10-independent and associated with an increase of CD25(+) cells 102
Arg16Gly 132-Adrenoreceptor Polymorphism in Severe Eosinophilic Asthma: Implications for Mepolizumab Long-Term Effectiveness and Clinical Remission 87
Ruolo dei calcio-antagonisti nella prevenzione e nel trattamento dell’asma bronchiale 84
An Analytical Method for Assessing Optimal Storage Conditions of Gingival Crevicular Fluid and Disclosing a Peptide Biomarker Signature of Gingivitis by MALDI-TOF MS 81
Effects of budesonide on p38 MAPK activation, apoptosis and IL-8 secretion, induced by TNF-α and Haemophilus influenzae in human bronchial epithelial cells 78
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study 74
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 71
Application of proteomics and peptidomics to COPD 70
High-flow nasal oxygen therapy in intensive care and anaesthesia 67
Biological mechanisms underlying the clinical effects of allergen-specific immunotherapy in asthmatic children 64
Rapid detection and identification of antimicrobial peptide fingerprints of nasal fluid by mesoporous silica particles and MALDI-TOF/TOF mass spectrometry: from the analytical approach to the diagnostic applicability in precision medicine 63
Asthma and COPD proteomics: Current approaches and future directions 62
Covid-19 and the role of smoking: The protocol of the multicentric prospective study COSMO-IT (covid19 and smoking in italy) 62
High-flow nasal cannula oxygen therapy for outpatients undergoing flexible bronchoscopy: a randomised controlled trial 62
Effects of the first three doses of benralizumab on symptom control, lung function, blood eosinophils, oral corticosteroid intake, and nasal polyps in a patient with severe allergic asthma 61
The sodium-phosphate co-transporter SLC34A2, and pulmonary alveolar microlithiasis: presentation of an inbred family and a novel truncating mutation in exon 3 60
A rapid differential display analysis of nasal swab fingerprints to distinguish allergic from non-allergic rhinitis subjects by mesoporous silica particles and MALDI-TOF mass spectrometry 59
Interleukin-6 receptor superantagonist Sant7 inhibits TGF-beta-induced proliferation of human lung fibroblasts 58
A case of Hughes-Stovin sindrome associated with Budd-Chiari sindrome 57
Peptidomic analysis of induced sputum of asthmatic patients by MSB-MALDI-TOF-MS platform 57
Asthma management in a specialist setting: results of an Italian Respiratory Society survey 56
New treatments for asthma: From the pathogenic role of prostaglandin D2 to the therapeutic effects of fevipiprant 56
Type 2 severe asthma: pathophysiology and treatment with biologics 55
Benralizumab in the treatment of severe asthma: design, development and potential place in therapy 55
A case of alveolar proteinosis associated with pulmonary nocardiosis 55
Adverse drug reactions to antibiotics observed in two pulmonology divisions of Catanzaro, Italy: A six-year retrospective study 55
Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseases 55
A case of Hughes-Stovin syndrome associated with Budd-Chiari syndrome 55
A single-blind comparative study of the effects of inhaled fluticasone propionate and nedocromil sodium on airway hyperresponsiveness to methacholine 54
Alpha-interferon and its effects on signal transduction pathways 53
Is the mitochondrial benzodiazepine receptor involved in the control of airway smooth muscle tone? 53
LEBRIKIZUMAB Anti-interleukin-13 monoclonal antibody, Treatment of asthma 53
Airways smooth muscle response to biological stimuli 52
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study 51
Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug dose 51
Theophylline action on primary human bronchial epithelial cells under proinflammatory stimuli and steroidal drugs: a therapeutic rationale approach 51
A rapid differential display analysis of nasal swab fingerprints to distinguish allergic from non-allergic rhinitis subjects by mesoporous silica particles and MALDI-TOF mass spectrometry 51
Application of MSB-MALDI-TOF-MS Technology to body fluids and Tissues peptidome profiling 50
Anticolinergici 50
Endothelin-1 induces proliferation of human lung fibroblasts and IL-11 secretion through an ET(A) receptor-dependent activation of MAP kinases 50
Adverse drug reactions in hospitalized patients following antibiotics administration 49
Anti-IgE therapy with omalizumab for severe asthma: current concepts and potential developments 49
Valutazione in doppio cieco dell’effetto broncodilatante del procaterolo somministrato per aerosol dosato 49
Objective and self-evaluation voice analysis after transoral laser cordectomy and radiotherapy in T1a-T1b glottic cancer 49
Benralizumab:from the basic mechanism of action to the potential use in the biological therapy of severe eosinophilic asthma 48
Adverse drug reactions in hospitalized patients following NSAIDs administration 48
Influence of storage conditions on MALDI-TOF MS profiling of gingival crevicular fluid: Implications on the role of S100A8 and S100A9 for clinical and proteomic based diagnostic investigations 48
A single-blind, partial crossover clinical trial of the effects of inhaled fluticasone propionate and nedocromil sodium on airway hyperresponsiveness to methacholine 48
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super-Response and Remission With Mepolizumab 47
Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non small lung cancer cells. 47
Agonisti beta2-adrenergici 47
Early management of COPD: where are we now and where do we go from here? 47
Adverse drug reaction in two pneumology units of Catanzaro 47
Molecular mechanisms underlying airway smooth muscle contraction and proliferation: Implications for asthma 47
A rare case of infection of the lower respiratory tract caused by Bordetella bronchiseptica 46
Emerging biological treatments for asthma 45
Kartagener's syndrome in a woman with a normal ciliary structure and an intracranial meningioma 45
Effects of Ambrisentan in a Patient Affected by Combined Pulmonary Fibrosis and Emphysema and by Severe Pulmonary Hypertension: Clinical, Functional, and Biomolecular Findings 45
Adverse drug reactions in hospitalized patients following bronchodilators administration 45
Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence 44
The severe asthma network in Italy: findings and perspectives 43
Inhibitory effects of the IL-6 receptor superantagonist SANT7 on MAP kinase phosphorylation and cell proliferation induced by IL-6 and TGF-beta1in human lung fibroblasts 43
Effects of MAPK inhibitors on H2O2-induced IL-8 production and cell death in primary cultures of human bronchial epithelial cells 43
Basi fisiopatologiche della terapia del broncospasmo 43
Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxide 43
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy 43
Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for biomarker discovery of Asthma and COPD 43
Effects of transforming growth factor-β and budesonide on mitogen-activated protein kinase activation and apoptosis in airway epithelial cells 43
Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis 43
Neuron-specific enolase serum levels in COVID-19 are related to the severity of lung injury 43
An integrated metabo-lipidomics profile of induced sputum for the identification of novel biomarkers in the differential diagnosis of asthma and COPD 42
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study 42
Oxygenation strategies during flexible bronchoscopy: a review of the literature 42
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial 42
Real-world experience with benralizumab in patients with severe eosinophilic asthma: A case series 42
Real-Life Clinical and Functional Effects of Fluticasone Furoate/Umeclidinium/Vilanterol-Combined Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease 42
Persistence of both reversible airway obstruction and higher blood eosinophils may predict lung function decline in severe asthma 42
Role of biologics in severe eosinophilic asthma - focus on reslizumab 41
Ascaris lumbricoides-induced suppression of total and specific IgE responses in atopic subjects is interleukin 10-indipendent and associated with an increase of CD25+ cells 41
T CELL ACTIVATION STATE IN THE INDUCED SPUTUM OF ASTHMATICS TREATED WITH BUDESONIDE 41
Ruolo dell’endotelio nella regolazione del circolo polmonare 41
Clinical relevance of understanding mitogen-activated protein kinases involved in asthma 41
Phenotyping severe asthma: a rationale for biologic therapy 41
Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study 41
Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma 41
Treatment of COPD by dual bronchodilation with co-formulation of indacaterol/glycopyrronium 40
Fisiopatologia del Broncospasmo 40
Patogenesi e terapia dell’asma bronchiale: recenti acquisizioni, 40
Retrospective analysis of adverse drug reactions induced by gemcitabine treatment in patients with non-small cell lung cancer 40
Enfisema polmonare 39
P38 signalling pathway in primary cultures of human bronchial epithelial cells: effects of transforming growth factor-β and pharmacological modulation by budesonide 39
Characteristics and treatment regimens across ERS SHARP severe asthma registries 39
Switch from omalizumab to benralizumab in allergic patients with severe eosinophilic asthma: A real-life experience from Southern Italy 39
Real-life evaluation of the clinical, functional, and hematological effects of mepolizumab in patients with severe eosinophilic asthma: Results of a single-centre observational study 39
Shadow cost of oral corticosteroids-related adverse events: a pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry. 38
Applicazioni della Biologia Molecolare alle Malattie Respiratorie 38
Effects of hydrogen peroxide on MAPK activation, IL-8 production and cell viability in primary cultures of human bronchial epithelial cells 38
Switching from omalizumab to mepolizumab: real-life experience from Southern Italy 38
Real-life evaluation of mepolizumab efficacy in patients with severe eosinophilic asthma, according to atopic trait and allergic phenotype 38
Real-Life effects of benralizumab on exacerbation number and lung hyperinflation in atopic patients with severe eosinophilic asthma 38
Totale 5.015
Salva come PNG Salva come JPEG
Categoria #
all - tutte 112.524
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 112.524
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021150 0 0 0 0 0 13 7 6 86 25 6 7
2021/2022584 4 5 19 111 46 18 31 141 53 57 89 10
2022/20231.692 465 65 66 127 182 169 16 116 276 78 110 22
2023/2024686 143 90 59 37 36 169 14 24 8 27 24 55
2024/20252.718 412 137 97 105 194 344 93 75 348 144 280 489
2025/20263.879 325 754 762 1.269 643 126 0 0 0 0 0 0
Totale 10.018